• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • The Team
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • EMIS Impact and Investment Fund (IIF)
      • Medicine Management
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • Specialties
        • EMIS: Cancer Guide
        • EMIS Cardiovascular Overview
          • EMIS: Cardiovascular Disease (AF, CHD, Hypertension)
          • EMIS: Cardiovascular Disease (CVD) Prevention
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • EMIS: Peripheral Arterial Disease Guide
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS Renal Overview
          • Chronic Kidney Disease (CKD) – EMIS
        • Respiratory Overview
          • EMIS Asthma Resources
          • BeatAsthma+ Guide for EMIS
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • Vaccinations
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes Management
          • SystmOne Diabetes Prevention
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid Lowering Template
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Asthma Resources
          • Respiratory Infections
        • Rheumatology Overview
          • Bone Health
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / EMIS Resource Centre / Medicine Management / EMIS: Safe Prescribing of Opioids / Opiates

EMIS: Safe Prescribing of Opioids / Opiates

Harm caused by Opioid medication is a major cause for concern. NICE guidance recommends that Opioids are unlikely to be suitable for controlling primary chronic pain. A series of resources are available to help support harm reduction.

Population Reporting Searches

Accessing the Opioid Population Reporting Searches

To access the CDRC Opioid Population Reporting Searches / Reports on EMIS, you will need to download and import the following .zip file:

CDRC Quality Pain (15th May 2023)Download

If you have not performed this process before, please refer to the Download/ Import guide below, which provides you with step-by-step instructions on how to Download and Import .zip files into EMIS:

EMIS Zip File Download and Import GuideDownload

You can check whether you have the most up-to-date version by reviewing the date on the .zip file. Any updates to the Population Reporting searches will be communicated to CDRC Precision users via the mailing list for the CDRC. To ensure you stay up to date with the latest information, please sign up to the mailing list at http://eepurl.com/9131L 


Guidance on the Opioid Population Reporting Searches

The following searches are included in the above CDRC Quality Pain zip.file.

Searches ? Opioids 1.1 – 1.6 exclude patients on the palliative care register or taking methadone.

Searches ? Opioids 1.1 – 1.7 detect medication on repeat or being issued repeatedly over the past 3 months.

Tackling opioid use can feel like an overwhelming issue. The searches are designed to help divide this work into manageable chunks, starting with the highest risk patients. 

Search Patients Action 
? Opioids 1.1 Likely to be on >100mg morphine equivalentLikely to be having medication with a morphine equivalent (Meq) dose of >100mg / day Review patients. Patients requiring >100mg are unlikely to have an opioid responsive pain. Some guidelines recommended reduction and cessation of opioids 
? Opioids 1.2 Likely to be on >80mg morphine equivalentPatients that are likely to be medication with a morphine equivalent dose of >=80mgReview patients and consider dose reduction. 
? Opioids 1.21 Likely to be on >80mg morphine equivalent (excl >100mg morphine equivalent)Patients that are likely to be medication with a morphine equivalent dose of >=80mg, excluding patients with a morphine equivalent dose of >=100mg
? Opioids 1.3 Likely to be on >50mg morphine equivalentLikely to be having medication with a morphine equivalent (MEq) dose of >50mg / dayReview patients and consider dose reduction. 
? Opioids 1.4 Any high strength opiatePatients receiving high strength opioids such as morphine, buprenorphine and fentanyl Review patients and consider dose reduction. 
? Opioids 1.5 Any instant release opiatePatients receiving instant release opioids such as oramorph or oxynorm Guidelines suggest that instant release opioids are unlikely to be suitable for chronic pain.  Review patient and consider reduction or cessation 
? Opioids 1.6 Any OpioidPatients receiving any opioid Review patients and consider dose reduction. 
? Opioids 1.6.1 Opioid / other analgesic combination products – should be avoidedPatients receiving combination products such as co-cocodamol or codydramol. These products are considered to be less suitable. Review patient and consider reduction, cessation or switching to separate medications. 
? Opioid 1.6.2 Codeine 30mg – consider reduction to 15mg Patients receiving codeine 30mg tablets Patients could be offered 15mg tablets instead to allow them to take smaller doses. 
? Opioid 1.6.3  Dihydrocodeine – should be avoidedPatients receiving dihydrocodeine Some areas have indicated that this drug is no longer suitable for prescribing.  Review patients and consider reduction/cessation 
? Opioid 1.7 Methadone or possible opioid substitutionPatients likely to be receiving opioid substitution For reference. Consider review. 
? Opioid 2.1 Any opioid on repeat – not issued in the last 6 monthsPatients with opioid on repeat which have not been  issued in the last 6 months Consider removing from repeat prescription 
? Opioid 2.2 Any opioid on repeat – not issued in the last 3 monthsPatients with opioid on repeat which have not been  issued in the last 3 months Consider removing from repeat prescription 
? Opioid 3.1 Opioids and Benzodiazepines MHRA warning
? Opioid 3.11 Opioids and Benzodiazepines MHRA warning (not palliative care)
Patients receiving opioids and benzodiazepines MHRA warning (additional search to exclude palliative care patients) This high risk combination has a high risk of respiratory depression and review/reduction/cessation should be considered 
? Opioid 3.2 Oxycodone and TCA – Coroner’s warning
? Opioid 3.21 Oxycodone and TCA – Coroner’s warning (not palliative care)
Patients receiving oxycodone and tricyclic antidepressants coroner’s warning (additional search to exclude palliative care patients) This high risk combination has a high risk of respiratory depression and review/reduction/cessation should be considered 

NIPP Project Study Guidance

The Searches required for this study are included in the above CDRC Quality Pain zip.file (Expand the Accessing the Opioid Population Reporting Searches node).

CDRC has created several searches to identify and prioritise patients currently taking opioid medication to potentially reduce their opioid dosage or to substitute their opioid medication for a safer alternative. Not all of these searches are applicable to the NHS Insights Prioritisation Programme (NIPP) opioid study.

For the NIPP Project, a member of staff at your EMIS practice will run and report on the following searches:

  • ? Opioids 1.1 Likely to be on >100mg morphine equivalent
  • ? Opioids 1.21 Likely to be on >80mg morphine equivalent (not >100mg morphine equivalent)
  • ? Opioids 1.6  Any Opioid

These searches are found in the CDRC Quality > Pain folder and are highlighted below:

NIPP Study Criteria:

Patients targeted will include adults (aged 18 or over) registered with a mobile phone number at practices and those regularly taking opioids for more than 90 days and at dose equivalent to ≥ 90 mg equivalent of morphine a day (this varies for each opioid medication) using electronic records. Patients will be excluded if they are coded cancer or palliative care. Eligible patients will be screened and identified by primary care staff in the participating practices.

Please note:

  • The highlighted searches above exclude patients on palliative care, or taking Methadone/Subutex.
  • These searches include opioids on repeat prescription or >=2 scripts in the last 3 months as a proxy for usage over 90d.
  • The opioid drug combination required to meet the >90mg morphine equivalence is very rare, thus CDRC has created searches ? Opioids 1.1 and ? Opioids 1.2/1.21 to reflect the inclusion criteria as closely as possible.

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
  • Terms of Reference
  • Privacy policy
  • Terms of use

Copyright © 2023 Clinical Digital Resource Collaborative